Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Glaxosmithkline (GSK) Share News

LONDON BROKER RATINGS: UBS likes LSEG; BofA lifts Weir Group

17th Mar 2023 09:32

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday: Read More

LONDON BRIEFING: Emis takeover and BT Openreach get watchdog scrutiny

17th Mar 2023 07:53

(Alliance News) - London's FTSE 100 is called to open higher on Friday, ending a tumultuous week in the green. Read More

GSK lauds trial findings; asthma drug backed for review in China

14th Mar 2023 09:41

(Alliance News) - GSK PLC said on Tuesday its asthma drug was accepted for review in China, while it also reported a trial for a drug to treat an infectious disease met its primary endpoint. Read More

Sareum says GSK's Sierra returns clinical study reports to CRT Pioneer

6th Mar 2023 11:19

(Alliance News) - Sareum Holdings PLC on Monday said that GSK PLC subsidiary Sierra Oncology Inc has completed the return of the clinical study reports relating to SRA737 to Sarerum's co-development partner CRT Pioneer Fund LP. Read More

TOP NEWS: Haleon revenue up; records loss due to GSK demerger costs

2nd Mar 2023 11:13

(Alliance News) - Haleon PLC on Thursday said revenue was up, as it declares its inaugural dividend following its GSK split. Read More

LONDON BROKER RATINGS: Numis cuts BT to 'sell'; Citigroup cuts Babcock

2nd Mar 2023 09:48

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning: Read More

LONDON MARKET OPEN: CRH shares jump as it plans US primary listing

2nd Mar 2023 09:13

(Alliance News) - Stock prices in London were lower early Thursday, with the FTSE 100 index being spared from a steeper fall thanks to a jump in CRH shares and a weaker pound. Read More

LONDON BRIEFING: Taylor Wimpey expects house completions to drop

2nd Mar 2023 07:57

(Alliance News) - Stocks were called to open flat in London, with market attention on a raft of corporate earnings, as well as a eurozone inflation reading at 1000 GMT. Read More

US FDA panel supports GSK vaccine ahead of approval decision

2nd Mar 2023 07:00

(Alliance News) - GSK PLC on Wednesday said the US Food & Drug Administration's advisory committee voted to support its respiratory syncytial virus vaccine candidate for older adults. Read More

LONDON MARKET EARLY CALL: Stocks called higher; pound below USD1.20

2nd Mar 2023 06:56

(Alliance News) - Stocks in London are set to open higher on Thursday, ahead of a eurozone inflation reading. Read More

LONDON BROKER RATINGS: Citi cuts Quilter to 'sell'; Goldman likes GSK

27th Feb 2023 09:26

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday: Read More

LONDON MARKET CLOSE: FTSE 100 struggles, but European peers rise

23rd Feb 2023 17:00

(Alliance News) - Stock prices in London closed mixed on Thursday, with blue-chips ending in the red on renewed concerns of higher rates in the US, as well as a host of stocks going ex-dividend. Read More

GSK, Pfizer venture says HIV injectable therapy preferred in trial

23rd Feb 2023 09:02

(Alliance News) - GSK PLC on Thursday said that ViiV Healthcare has found that its injectable Cabenuva is as effective as the daily oral Biktarvy in treating HIV-1. Read More

GSK, Pfizer joint venture gets EU marketing approval for HIV treatment

22nd Feb 2023 13:13

(Alliance News) - ViiV Healthcare on Wednesday said it received marketing authorisation from the European Commission for Triumeq PD, a treament for children living with HIV Read More

UK dividends calendar - next 7 days

16th Feb 2023 15:47

Read More

GSK hails positive phase III trial results for RSV vaccine candidate

16th Feb 2023 09:04

(Alliance News) - GSK PLC on Thursday said a New England Journal of Medicine publication announced positive phase III trial results for its respiratory syncytial virus vaccine candidate for older adults. Read More

LONDON BROKER RATINGS: Shell, Glencore, Smurfit and abrdn ratings cut

10th Feb 2023 09:52

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning: Read More

TOP NEWS: GSK's Jemperli wins approval and trial evaluation in US

10th Feb 2023 08:04

(Alliance News) - GSK PLC on Friday said its drug Jemperli won a regular approval for a form of endometrial cancer and is set to be evaluated for a form of advanced rectal cancer in the US. Read More

GSK gets FDA approval for drug to treat anaemia in adults on dialysis

2nd Feb 2023 09:26

(Alliance News) - GSK PLC on Thursday said its Jesduvroq drug has been approved by the US Food & Drug Administration for anaemia of chronic kidney disease in adults on dialysis. Read More

LONDON BROKER RATINGS: Goldman Sachs cuts Standard Chartered

2nd Feb 2023 09:19

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning: Read More

FTSE 100 Latest
Value8,809.74
Change53.53